当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析

海尔生物

(688139)

  

流通市值:111.63亿  总市值:111.63亿
流通股本:3.18亿   总股本:3.18亿

海尔生物(688139)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.02亿元,每股收益0.63元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益458537.59万元,未分配利润211125.81万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产565044.44万元,负债106506.85万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,761,188,311.041,195,500,051.78688,989,400.72,283,832,911.43
营业总成本1,585,741,477.61,066,058,361.3575,353,290.721,941,857,521.47
其他经营收益
营业利润211,839,125.16157,537,694.29126,546,211.91401,827,808.74
利润总额210,184,973.39156,193,043.7125,489,878.45401,956,704.73
净利润202,139,492.05147,213,041.4116,197,969.19381,008,045.8
每股收益
其他综合收益297,407.11625,201.66457,278.77-13,065,819.88
综合收益总额202,436,899.16147,838,243.06116,655,247.96367,942,225.92
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,550,077,650.982,607,094,479.982,863,421,109.962,652,447,941.35
非流动资产:
非流动资产合计3,100,366,771.463,004,985,131.762,967,019,491.483,135,020,853.66
资产总计5,650,444,422.445,612,079,611.745,830,440,601.445,787,468,795.01
流动负债:
流动负债合计926,292,638.32897,276,443.44966,907,036.971,022,403,542.51
非流动负债:
非流动负债合计138,775,837.59156,432,636.53154,732,287.72146,929,219.71
负债合计1,065,068,475.911,053,709,079.971,121,639,324.691,169,332,762.22
所有者权益(或股东权益):
归属于母公司股东权益合计4,335,622,713.14,307,982,184.484,456,255,374.14,371,550,511.01
股东权益合计4,585,375,946.534,558,370,531.774,708,801,276.754,618,136,032.79
负债和股东权益合计5,650,444,422.445,612,079,611.745,830,440,601.445,787,468,795.01
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,759,634,618.611,199,365,522.61580,704,504.072,429,286,249.01
经营活动现金流出小计1,676,991,482.291,163,725,455.85543,485,302.532,137,619,330.75
经营活动产生的现金流量净额82,643,136.3235,640,066.7637,219,201.54291,666,918.26
投资活动产生的现金流量:
投资活动现金流入小计3,157,342,428.912,293,110,996.441,109,537,955.232,981,647,918.69
投资活动现金流出小计3,082,317,227.092,291,615,423.751,027,103,424.733,772,864,625.61
投资活动产生的现金流量净额75,025,201.821,495,572.6982,434,530.5-791,216,706.92
筹资活动产生的现金流量:
筹资活动现金流入小计558,303,291.65378,868,861.1194,362,611.12193,985,922.8
筹资活动现金流出小计803,835,135.62594,403,076.26212,531,263.4420,813,197.24
筹资活动产生的现金流量净额-245,531,843.97-215,534,215.16-18,168,652.28-226,827,274.44
汇率变动对现金及现金等价物的影响1,655,825.715,555,997.041,204,511.814,434,529.58
现金及现金等价物净增加额-86,207,680.12-172,842,578.67102,689,591.57-721,942,533.52
期末现金及现金等价物余额448,496,350.56361,861,452.01637,393,622.25534,704,030.68
补充资料:
现金及现金等价物的净增加额--172,842,578.67--721,942,533.52
最新报告期:2025-09-17
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华创证券郑辰,李婵娟1.331.601.842025-09-17
东海证券杜永宏1.281.511.772025-09-01
TOP↑